Our purpose Optimised transdermal delivery of Naltrexone
Libero has a pipeline of tailored Naltrexone transdermal patches targeting multiple indications with significant and growing unmet need
Addiction Opioid Use Disorder, Alcohol Use Disorder, Fibromyalgia, Crohn’s disease - the prevalence of all four conditions is on the rise
New therapeutic options are urgently needed; evidence supports the benefits of Naltrexone yet patient access is limited inflammation
Find out more A new way for 450 million people to access proven medicines
Naltrexone and Naloxone have vast untapped potential to help address unmet patient need